<--- Back to Details
First PageDocument Content
Biology / CSL Limited / CSL Behring / Gardasil / Influenza vaccine / Intravenous immunoglobulin / FluMist / Exchange rate / Behring / Vaccines / Medicine / Pharmacology
Date: 2009-10-22 08:48:07
Biology
CSL Limited
CSL Behring
Gardasil
Influenza vaccine
Intravenous immunoglobulin
FluMist
Exchange rate
Behring
Vaccines
Medicine
Pharmacology

Microsoft PowerPoint[removed]AGM - CEO - ASX-website.ppt

Add to Reading List

Source URL: www.csl.com.au

Download Document from Source Website

File Size: 129,63 KB

Share Document on Facebook

Similar Documents

CSL Behring AG WankdorfstrasseBern 22 Switzerland sitem-insel AG

DocID: 1uREs - View Document

News Releases Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites  

DocID: 1sx8q - View Document

Uwe E. Jocham Direktionspräsident CSL Behring Recombinant Facility AG, Lengnau/Schweiz Uwe E. Jocham, geboren in Frankfurt, Deutschland, studierte Pharmazie an der LudwigMaximilians-Universität (LMU) in München. Nach

DocID: 1sesH - View Document

MAJOR THERAPEUTIC PRODUCTS MARKETED by CSL Behring Hematology Specialty Care

DocID: 1sb17 - View Document

CSL Behring / Coagulation

[Product Monograph Template - Schedule D]

DocID: 1rjWd - View Document